TretinoinKeratolytic AgentsAntineoplastic Combined Chemotherapy ProtocolsLentigoAcne VulgarisOintmentsAdministration, TopicalSkin AgingCosmeticsChemotherapy, AdjuvantChemexfoliationDermatologic AgentsHyperpigmentationAcitretinAntineoplastic AgentsMelanosisNicotinic AcidsEmollientsTrichloroacetic AcidKeratosis, ActinicSkin CareTreatment OutcomeCombined Modality TherapyFacial InjuriesCisplatinCyclophosphamideCarcinoma, Basal CellDoxorubicinNeoadjuvant TherapyDisease-Free SurvivalRetinoidsSkinEtoposideBreast NeoplasmsAdministration, CutaneousNeoplasm StagingSurvival AnalysisSkin PigmentationPrognosisSurvival RateDrug CombinationsLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmDouble-Blind MethodBleomycinNeoplasmsDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseTime FactorsColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticDacarbazineClinical Trials as TopicProspective StudiesNeoplasms, Germ Cell and EmbryonalCarmustineLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone NeoplasmsInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinThiotepa